Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ackerman

Showing results (741-750 of 1,140) with videos related to

Pageof 114
Sort By:
Circulation|October 21, 2009
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variantsSuraj Kapa, David J Tester, Benjamin A Salisbury, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 6, 2021
Changes in ion channel expression and function associated with cardiac arrhythmogenic remodeling by Sorbs2Ling-Ling Qian, Xiaojing Sun, Jingchun Yang, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 9, 2025
Prevalence & Economic Burden of Adult Spinal Deformity in a Large United States Commercial Payer PopulationJayme C B Koltsov, Stacey J Ackerman, Kelly H McFarlane, et al.
Scientific Reports|April 24, 2025
Maturation of human induced pluripotent stem cell-derived cardiomyocytes promoted by Brachyury primingParisa K Kargaran, Armin Garmany, Ramin Garmany, et al.
Circulation. Cardiovascular Genetics|May 17, 2013
Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndromeNicole J Boczek, Jabe M Best, David J Tester, et al.
Journal of Endourology|March 14, 2002
Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapyMichael J Manyak, Stacey J Ackerman, Michael L Blute, et al.
Toxicology and Applied Pharmacology|October 1, 1984
Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 ratsD W Lynch, T R Lewis, W J Moorman, et al.
Heart Rhythm|April 21, 2010
Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutationDavid J Tester, Carmen Valdivia, Carole Harris-Kerr, et al.
Circulation. Genomic and Precision Medicine|May 30, 2020
Corrected QT Interval-Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family MembersKari L Turkowski, Steven M Dotzler, David J Tester, et al.
Journal of Cardiovascular Translational Research|February 26, 2016
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic CardiomyopathySinead L Murphy, Jason H Anderson, Jamie D Kapplinger, et al.
Pageof 114

Showing results (741-750 of 1,140) with videos related to

Sort By:
Pageof 114
Circulation|October 21, 2009
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variantsSuraj Kapa, David J Tester, Benjamin A Salisbury, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 6, 2021
Changes in ion channel expression and function associated with cardiac arrhythmogenic remodeling by Sorbs2Ling-Ling Qian, Xiaojing Sun, Jingchun Yang, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 9, 2025
Prevalence & Economic Burden of Adult Spinal Deformity in a Large United States Commercial Payer PopulationJayme C B Koltsov, Stacey J Ackerman, Kelly H McFarlane, et al.
Scientific Reports|April 24, 2025
Maturation of human induced pluripotent stem cell-derived cardiomyocytes promoted by Brachyury primingParisa K Kargaran, Armin Garmany, Ramin Garmany, et al.
Circulation. Cardiovascular Genetics|May 17, 2013
Exome sequencing and systems biology converge to identify novel mutations in the L-type calcium channel, CACNA1C, linked to autosomal dominant long QT syndromeNicole J Boczek, Jabe M Best, David J Tester, et al.
Journal of Endourology|March 14, 2002
Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapyMichael J Manyak, Stacey J Ackerman, Michael L Blute, et al.
Toxicology and Applied Pharmacology|October 1, 1984
Carcinogenic and toxicologic effects of inhaled ethylene oxide and propylene oxide in F344 ratsD W Lynch, T R Lewis, W J Moorman, et al.
Heart Rhythm|April 21, 2010
Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutationDavid J Tester, Carmen Valdivia, Carole Harris-Kerr, et al.
Circulation. Genomic and Precision Medicine|May 30, 2020
Corrected QT Interval-Polygenic Risk Score and Its Contribution to Type 1, Type 2, and Type 3 Long-QT Syndrome in Probands and Genotype-Positive Family MembersKari L Turkowski, Steven M Dotzler, David J Tester, et al.
Journal of Cardiovascular Translational Research|February 26, 2016
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic CardiomyopathySinead L Murphy, Jason H Anderson, Jamie D Kapplinger, et al.
Pageof 114